SCHEMBL2806223

SCHEMBL2806223

CCCCC#Cc1cccc(N)c1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.49
CYP2C9 P11712 4/20 0.49
CYP2C19 P33261 4/20 0.49
KDM4E B2RXH2 3/20 0.49
MAPT P10636 3/20 0.49
CYP1A2 P05177 3/20 0.49
ALDH1A1 P00352 3/20 0.49
TSHR P16473 2/20 0.42
PIK3CA P42336 1/20 0.42
KCNH2 Q12809 1/20 0.41
HSD17B10 Q99714 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
LMNA P02545 1/20 0.41
CYP2D6 P10635 1/20 0.41
APEX1 P27695 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HPGD P15428 1/20 0.40
ALOX12 P18054 1/20 0.40
TLR8 Q9NR97 1/20 0.37
CYSLTR2 Q9NS75 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7833889 0.84 CYP3A4 (0.67) CYP3A4CYP2C9CYP2C19KDM4EMAPT
SCHEMBL31026506 0.84 CYP3A4 (0.67) CYP3A4CYP2C9CYP2C19KDM4EMAPT
SCHEMBL2808025 0.82 CYP3A4 (0.48) CYP3A4CYP2C9CYP2C19KDM4EMAPT
SCHEMBL2814495 0.80 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19KDM4EMAPT
SCHEMBL6693749 0.79 CYP3A4 (0.70) CYP3A4CYP2C9CYP2C19KDM4EMAPT
SCHEMBL29386254 0.78 CYP3A4 (0.68) CYP3A4CYP2C9CYP2C19KDM4EMAPT
SCHEMBL31333138 0.78 CYP3A4 (0.68) CYP3A4CYP2C9CYP2C19KDM4EMAPT
SCHEMBL22748360 0.74 KCNH2 (0.50) CYP3A4CYP2C9CYP2C19KDM4EMAPT
SCHEMBL22748238 0.74 KCNH2 (0.50) CYP3A4CYP2C9CYP2C19KDM4EMAPT
SCHEMBL2814494 0.73 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286353-A1 ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF FUJIFILM CORPORATION (JP) 2010-11-11 US disclosed
US-20100240908-A1 ACETYLENE COMPOUND FUJIFILM CORPORATION (JP) 2010-09-23 US disclosed
EP-2202221-A1 ACETYLENE COMPOUND Fujifilm Corporation (JP) 2010-06-30 EP disclosed
EP-2202220-A1 ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF Fujifilm Corporation (JP) 2010-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240908-A1 ACETYLENE COMPOUND NAT1, KATNA1, KAT2B CYP3A4 1909/4885CYP2C9 1564/4885CYP2C19 1273/4885
US-20100286353-A1 ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF KAT8, HDAC10, SSRP1 CYP3A4 3918/4885CYP2C9 3857/4885CYP2C19 3730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.